{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:13:14Z","timestamp":1789038794682,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"DOI":"10.1007\/s12185-026-04277-0","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:55:03Z","timestamp":1789037703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of carotid intima media thickness with cardiovascular disease risk in immune thrombocytopenia"],"prefix":"10.1007","author":[{"given":"Mohamed","family":"Abdelhadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan Aly","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8227-9938","authenticated-orcid":false,"given":"Nabil Mahmoud","family":"Abdelfattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mahmoud","family":"Khallaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafiq Naguib","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"4277_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2024.101222","volume":"67","author":"JW Semple","year":"2024","unstructured":"Semple JW, Schifferli A, Cooper N, et al. Immune thrombocytopenia: pathophysiology and impacts of Romiplostim treatment. Blood Rev. 2024;67:101222. https:\/\/doi.org\/10.1016\/j.blre.2024.101222.","journal-title":"Blood Rev"},{"key":"4277_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29245\/2578-3009\/2020\/2.1185","volume":"4","author":"PR Lev","year":"2021","unstructured":"Lev PR, Goette NP, Marta RF. Pathophysiological mechanisms leading to low platelet count in immune thrombocytopenia. J Immunol Sci. 2021;4:1\u20137. https:\/\/doi.org\/10.29245\/2578-3009\/2020\/2.1185.","journal-title":"J Immunol Sci"},{"key":"4277_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/JCM6020016","volume":"6","author":"A Zufferey","year":"2017","unstructured":"Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017;6:16. https:\/\/doi.org\/10.3390\/JCM6020016.","journal-title":"J Clin Med"},{"key":"4277_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.21037\/AOB.2018.10.02","volume":"3","author":"J Zlamal","year":"2018","unstructured":"Zlamal J, Bakchoul T. Acquired immune thrombocytopenia: an update on pathophysiology, diagnosis and management. Ann Blood. 2018;3:45\u201345. https:\/\/doi.org\/10.21037\/AOB.2018.10.02.","journal-title":"Ann Blood"},{"key":"4277_CR5","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1182\/BLOOD-2008-09-181073","volume":"113","author":"W Zhang","year":"2009","unstructured":"Zhang W, Nardi MA, Borkowsky W, et al. Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia. Blood. 2009;113:4086\u201393. https:\/\/doi.org\/10.1182\/BLOOD-2008-09-181073.","journal-title":"Blood"},{"key":"4277_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jpeds.2009.10.015","volume":"156","author":"E Mantadakis","year":"2010","unstructured":"Mantadakis E, Farmaki E, Buchanan GR. Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management. J Pediatr. 2010;156:623\u20138. https:\/\/doi.org\/10.1016\/j.jpeds.2009.10.015.","journal-title":"J Pediatr"},{"key":"4277_CR7","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.1182\/BLOOD-2009-01-129155","volume":"113","author":"DB Cines","year":"2009","unstructured":"Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113:6511\u201321. https:\/\/doi.org\/10.1182\/BLOOD-2009-01-129155.","journal-title":"Blood"},{"key":"4277_CR8","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1111\/TRF.16368","volume":"61","author":"T Kewan","year":"2021","unstructured":"Kewan T, Gunaratne TN, Mushtaq K, et al. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience. Transfusion. 2021;61:2014\u20138. https:\/\/doi.org\/10.1111\/TRF.16368.","journal-title":"Transfusion"},{"key":"4277_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/medicina58020211","volume":"58","author":"CC T\u0103rniceriu","year":"2022","unstructured":"T\u0103rniceriu CC, Hurjui LL, Florea ID, et al. Immune thrombocytopenic purpura as a hemorrhagic versus thrombotic disease: an updated insight into pathophysiological mechanisms. Medicina (B Aires). 2022;58:211. https:\/\/doi.org\/10.3390\/medicina58020211.","journal-title":"Medicina (B Aires)"},{"key":"4277_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.thromres.2013.09.009","volume":"132","author":"DE Connor","year":"2013","unstructured":"Connor DE, Ma DDF, Joseph JE. Flow cytometry demonstrates differences in platelet reactivity and microparticle formation in subjects with thrombocytopenia or thrombocytosis due to primary haematological disorders. Thromb Res. 2013;132:572\u20137. https:\/\/doi.org\/10.1016\/j.thromres.2013.09.009.","journal-title":"Thromb Res"},{"key":"4277_CR11","doi-asserted-by":"publisher","unstructured":"Tantawy AAG, Matter RM, Hamed AA, El Din El Telbany MAS (2010) Platelet microparticles in immune thrombocytopenic purpura in pediatrics. Pediatr Hematol Oncol 27:283\u2013296. https:\/\/doi.org\/10.3109\/08880011003663390","DOI":"10.3109\/08880011003663390"},{"key":"4277_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2012.11.021","author":"EM Sewify","year":"2013","unstructured":"Sewify EM, Sayed D, Abdel Aal RF, et al. Increased circulating red cell microparticles (RMP) and platelet microparticles (PMP) in immune thrombocytopenic purpura. Thromb Res. 2013. https:\/\/doi.org\/10.1016\/j.thromres.2012.11.021.","journal-title":"Thromb Res"},{"key":"4277_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/BJH.14412","volume":"175","author":"MT \u00c1lvarez-Rom\u00e1n","year":"2016","unstructured":"\u00c1lvarez-Rom\u00e1n MT, Fern\u00e1ndez-Bello I, Jim\u00e9nez-Yuste V, et al. Procoagulant profile in patients with immune thrombocytopenia. Br J Haematol. 2016;175:925\u201334. https:\/\/doi.org\/10.1111\/BJH.14412.","journal-title":"Br J Haematol"},{"key":"4277_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1160\/TH13-10-0873","volume":"112","author":"MT \u00c1lvarez Rom\u00e1n","year":"2014","unstructured":"\u00c1lvarez Rom\u00e1n MT, Fern\u00e1ndez Bello I, Arias-Salgado EG, et al. Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia. Thromb Haemost. 2014;112:65\u201372. https:\/\/doi.org\/10.1160\/TH13-10-0873.","journal-title":"Thromb Haemost"},{"key":"4277_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2024.109109","author":"A Saldanha","year":"2024","unstructured":"Saldanha A, Colella MP, Villa\u00e7a PR, et al. The immune thrombocytopenia paradox: Should we be concerned about thrombosis in ITP? Thromb Res. 2024. https:\/\/doi.org\/10.1016\/j.thromres.2024.109109.","journal-title":"Thromb Res"},{"key":"4277_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2329-8790.1000185","volume":"3","author":"S Takagi","year":"2015","unstructured":"Takagi S, Suzuki I, Watanabe S. Risk of thromboembolism in patients with immune thrombocytopenia. J Hematol Thromboembolic Dis. 2015;3:1\u20139. https:\/\/doi.org\/10.4172\/2329-8790.1000185.","journal-title":"J Hematol Thromboembolic Dis"},{"key":"4277_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/RTH2.12592","volume":"5","author":"A Cuker","year":"2021","unstructured":"Cuker A, Liebman HA. Corticosteroid overuse in adults with immune thrombocytopenia: cause for concern. Res Pract Thromb Haemost. 2021;5:e12592. https:\/\/doi.org\/10.1002\/RTH2.12592.","journal-title":"Res Pract Thromb Haemost"},{"key":"4277_CR18","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/BLOODADVANCES.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3:3829\u201366. https:\/\/doi.org\/10.1182\/BLOODADVANCES.2019000966.","journal-title":"Blood Adv"},{"key":"4277_CR19","doi-asserted-by":"publisher","unstructured":"Vatvani AD, Hariyanto TI, Ramirez AC, Shabarek N Spleen and Bruton\u2019s tyrosine kinase inhibitors for the management of adult immune thrombocytopenia a systematic review and meta-analysis of randomized controlled trials. Clin Hematol Int 2025;7:76. https:\/\/doi.org\/10.46989\/001C.154588","DOI":"10.46989\/001C.154588"},{"key":"4277_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221149870","volume":"51","author":"X Li","year":"2023","unstructured":"Li X, Zhu W, Bao J, et al. Efficacy and safety of cyclosporine-based regimens for primary immune thrombocytopenia: a systematic review and meta-analysis. J Int Med Res. 2023;51:03000605221149870. https:\/\/doi.org\/10.1177\/03000605221149870.","journal-title":"J Int Med Res"},{"key":"4277_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.thromres.2019.04.016","volume":"178","author":"C Ekstrand","year":"2019","unstructured":"Ekstrand C, Linder M, Baricault B, et al. Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia\u2014results from two nationwide cohorts. Thromb Res. 2019;178:124\u201331. https:\/\/doi.org\/10.1016\/j.thromres.2019.04.016.","journal-title":"Thromb Res"},{"key":"4277_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.thromres.2018.10.017","volume":"172","author":"N Machin","year":"2018","unstructured":"Machin N, Ragni MV, Comer DM, Yabes JG. Prevalence and correlates of thrombosis in adults with immune thrombocytopenia: an NIS study. Thromb Res. 2018;172:80\u20135. https:\/\/doi.org\/10.1016\/j.thromres.2018.10.017.","journal-title":"Thromb Res"},{"key":"4277_CR23","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3324\/HAEMATOL.2009.018390","volume":"95","author":"A Sarpatwari","year":"2010","unstructured":"Sarpatwari A, Bennett D, Logie JW, et al. Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom general practice research database. Haematologica. 2010;95:1167\u201375. https:\/\/doi.org\/10.3324\/HAEMATOL.2009.018390.","journal-title":"Haematologica"},{"key":"4277_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/J.1365-2141.2012.09231.X","volume":"159","author":"M N\u00f8rgaard","year":"2012","unstructured":"N\u00f8rgaard M, Severinsen MT, Lund M\u00e6gb\u00e6k M, et al. Risk of arterial thrombosis in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study. Br J Haematol. 2012;159:109\u201311. https:\/\/doi.org\/10.1111\/J.1365-2141.2012.09231.X.","journal-title":"Br J Haematol"},{"key":"4277_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/EJH.12777","volume":"97","author":"IU Doobaree","year":"2016","unstructured":"Doobaree IU, Nandigam R, Bennett D, et al. Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis. Eur J Haematol. 2016;97:321\u201330. https:\/\/doi.org\/10.1111\/EJH.12777.","journal-title":"Eur J Haematol"},{"key":"4277_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/AJH.24234","volume":"91","author":"F Rodeghiero","year":"2016","unstructured":"Rodeghiero F. Is ITP a thrombophilic disorder? Am J Hematol. 2016;91:39\u201345. https:\/\/doi.org\/10.1002\/AJH.24234.","journal-title":"Am J Hematol"},{"key":"4277_CR27","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/S12185-016-1974-6","volume":"103","author":"WJ Langeberg","year":"2016","unstructured":"Langeberg WJ, Schoonen WM, Eisen M, et al. Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies. Int J Hematol. 2016;103:655\u201364. https:\/\/doi.org\/10.1007\/S12185-016-1974-6.","journal-title":"Int J Hematol"},{"key":"4277_CR28","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/BJH.17390","volume":"194","author":"D Swan","year":"2021","unstructured":"Swan D, Newland A, Rodegheiro F, Thachil J. Thrombosis in immune thrombocytopenia\u2013current status and future perspectives. Br J Haematol. 2021;194:822\u201334. https:\/\/doi.org\/10.1111\/BJH.17390.","journal-title":"Br J Haematol"},{"key":"4277_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/J.RPTH.2024.102342","volume":"8","author":"I Goncalves","year":"2024","unstructured":"Goncalves I, Lewis C, Grainger B, et al. Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes. Res Pract Thromb Haemost. 2024;8:102342. https:\/\/doi.org\/10.1016\/J.RPTH.2024.102342.","journal-title":"Res Pract Thromb Haemost"},{"key":"4277_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/hae.70187","volume":"32","author":"A Trillo","year":"2025","unstructured":"Trillo A, Hunter J, Ofir A, et al. Carotid intima-media thickness as a marker of subclinical atherosclerosis in adolescents with severe haemophilia. Haemophilia. 2025;32:418\u201324. https:\/\/doi.org\/10.1111\/hae.70187.","journal-title":"Haemophilia"},{"key":"4277_CR31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.61336\/EJCM\/25-07-97","volume":"15","author":"A Kumar","year":"2025","unstructured":"Kumar A, Sharma S, Ginni, et al. Association of internal carotid artery intima-media thickness with coronary artery disease and its predictive value to diagnose coronary atherosclerosis. Eur J Cardiovasc Med. 2025;15:577\u201380. https:\/\/doi.org\/10.61336\/EJCM\/25-07-97.","journal-title":"Eur J Cardiovasc Med"},{"key":"4277_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","volume":"21","author":"JH Stein","year":"2008","unstructured":"Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American society of echocardiography carotid intima-media thickness task force endorsed by the society for vascular medicine. J Am Soc Echocardiogr. 2008;21:93\u2013111. https:\/\/doi.org\/10.1016\/j.echo.2007.11.011.","journal-title":"J Am Soc Echocardiogr"},{"key":"4277_CR33","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/EURHEARTJ\/EHS092","volume":"33","author":"J Perk","year":"2012","unstructured":"Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). the fifth joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635\u2013701. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHS092.","journal-title":"Eur Heart J"},{"key":"4277_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.amjcard.2007.01.071","volume":"100","author":"MG Frontini","year":"2007","unstructured":"Frontini MG, Srinivasan SR, Xu JH, et al. Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (the Bogalusa heart study). Am J Cardiol. 2007;100:64\u20138. https:\/\/doi.org\/10.1016\/j.amjcard.2007.01.071.","journal-title":"Am J Cardiol"},{"key":"4277_CR35","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/vhrm.s6269","volume":"5","author":"J Mill\u00e1n","year":"2009","unstructured":"Mill\u00e1n J, Pint\u00f3 X, Mu\u00f1oz A, et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757. https:\/\/doi.org\/10.2147\/vhrm.s6269.","journal-title":"Vasc Health Risk Manag"},{"key":"4277_CR36","doi-asserted-by":"publisher","first-page":"1213275","DOI":"10.3389\/FMED.2023.1213275\/TEXT","volume":"10","author":"A Rahhal","year":"2023","unstructured":"Rahhal A, Provan D, Shunnar K, et al. Concurrent coronary artery disease and immune thrombocytopenia: a systematic review. Front Med. 2023;10:1213275. https:\/\/doi.org\/10.3389\/FMED.2023.1213275\/TEXT.","journal-title":"Front Med"},{"key":"4277_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/S12959-023-00545-9","volume":"21","author":"S Han","year":"2023","unstructured":"Han S, Lu H, Yu Y, et al. Hyperlipidemia in immune thrombocytopenia: a retrospective study. Thromb J. 2023;21:102. https:\/\/doi.org\/10.1186\/S12959-023-00545-9.","journal-title":"Thromb J"},{"key":"4277_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/JOIM.13794;CTYPE:STRING:JOURNAL","volume":"296","author":"N Li","year":"2024","unstructured":"Li N. Platelets as an inter-player between hyperlipidaemia and atherosclerosis. J Intern Med. 2024;296:39\u201352. https:\/\/doi.org\/10.1111\/JOIM.13794;CTYPE:STRING:JOURNAL.","journal-title":"J Intern Med"},{"key":"4277_CR39","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2025.2472461","author":"F Zhou","year":"2025","unstructured":"Zhou F, Zhang S, Li R, et al. A retrospective study of risk factors for thrombosis in patients with ITP. Hematology. 2025. https:\/\/doi.org\/10.1080\/16078454.2025.2472461.","journal-title":"Hematology"},{"key":"4277_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4274\/IMJ.GALENOS.2023.23682","volume":"24","author":"AC I\u015f\u0131k","year":"2023","unstructured":"I\u015f\u0131k AC, Erkek ET, Tuna MK, et al. Idiopathic thrombocytopenic purpura and cardiovascular disease: is elevated triglycerides to high-density lipoprotein cholesterol ratio a marker? Istanbul Med J. 2023;24:71\u20135. https:\/\/doi.org\/10.4274\/IMJ.GALENOS.2023.23682.","journal-title":"Istanbul Med J"},{"key":"4277_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJPC.2025.101011","volume":"22","author":"S Mitra","year":"2025","unstructured":"Mitra S, Biswas RK, Hooijenga P, et al. Carotid intima-media thickness, cardiovascular disease, and risk factors in 29,000 UK Biobank adults. Am J Prev Cardiol. 2025;22:101011. https:\/\/doi.org\/10.1016\/J.AJPC.2025.101011.","journal-title":"Am J Prev Cardiol"},{"key":"4277_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/AJH\/HPAE008","volume":"37","author":"TA Abe","year":"2024","unstructured":"Abe TA, Olanipekun T, Yan F, et al. Carotid intima-media thickness and improved stroke risk assessment in hypertensive Black adults. Am J Hypertens. 2024;37:290. https:\/\/doi.org\/10.1093\/AJH\/HPAE008.","journal-title":"Am J Hypertens"},{"key":"4277_CR43","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3390\/JCM14031033\/S1","volume":"14","author":"GR Mashaba","year":"2025","unstructured":"Mashaba GR, Phoswa WN, Lebelo SL, et al. A longitudinal cohort assessing the carotid intima-media thickness progression and cardiovascular risk factors in a rural black south African community. J Clin Med. 2025;14:1033. https:\/\/doi.org\/10.3390\/JCM14031033\/S1.","journal-title":"J Clin Med"},{"key":"4277_CR44","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/S40119-025-00428-2","volume":"14","author":"V Fern\u00e1ndez-Alvarez","year":"2025","unstructured":"Fern\u00e1ndez-Alvarez V, Linares-S\u00e1nchez M, L\u00f3pez F, et al. Role of arterial stiffness and carotid intima-media thickness on subclinical atherosclerosis and cardiovascular risk assessment. Cardiol Ther. 2025;14:367. https:\/\/doi.org\/10.1007\/S40119-025-00428-2.","journal-title":"Cardiol Ther"},{"key":"4277_CR45","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/S41392-025-02346-0","volume":"10","author":"MJ Herzog","year":"2025","unstructured":"Herzog MJ, M\u00fcller P, Lechner K, et al. Arterial stiffness and vascular aging: mechanisms, prevention, and therapy. Signal Transduct Target Ther. 2025;10:282. https:\/\/doi.org\/10.1038\/S41392-025-02346-0.","journal-title":"Signal Transduct Target Ther"},{"key":"4277_CR46","doi-asserted-by":"publisher","DOI":"10.4239\/WJD.V16.I12.114395","volume":"16","author":"H-Y Yang","year":"2025","unstructured":"Yang H-Y, Wei Y, Mao Q, Zhao L-H. Immune activation induced by dysregulated lipid metabolism in the pathogenesis of type 2 diabetes. World J Diabetes. 2025;16:114395. https:\/\/doi.org\/10.4239\/WJD.V16.I12.114395.","journal-title":"World J Diabetes"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04277-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04277-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04277-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:55:04Z","timestamp":1789037704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04277-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":46,"alternative-id":["4277"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04277-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}